Nuzenio

Cancer Drug With

Cancer Drug With news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 8 latest news signals 7 publisher sources 100/100 entity strength

Latest news

Samsung Bioepis Files South Korea's First Approval for Biosimilar of Merck's $32.4 Billion Cancer Drug Keytruda - finance.biggo.comfinance.biggo.com · Mon, 10 Aug 2026 09:15:00 GMTPatients in Illinois starting to receive experimental pancreatic cancer drug: ‘Game changer’ - Chicago TribuneChicago Tribune · Sun, 09 Aug 2026 11:00:17 GMTRecovery for Replimune: Accelerated Approval for Cancer Drug Twice Spurned by FDA - MedCity NewsMedCity News · Fri, 07 Aug 2026 22:12:34 GMTReplimune Wins FDA Skin Cancer Drug Approval on Third Try. Why the Stock Is Tumbling. - Barron'sBarron's · Fri, 07 Aug 2026 19:33:00 GMT'We're excited and ready to go': Fast-growing Revolution Medicines preps potential launch of blockbuster pancreatic cancer drug - The Business JournalsThe Business Journals · Fri, 07 Aug 2026 13:29:00 GMTFDA Approves Replimune Skin Cancer Drug After Rejections - MedscapeMedscape · Fri, 07 Aug 2026 13:27:22 GMT‘Concerning’ Trends in Cancer Drug Approvals - MedscapeMedscape · Fri, 07 Aug 2026 09:40:52 GMTAfter cancer drug counterfeiting scandal, India imposes new tracing requirements - International Consortium of Investigative Journalists - ICIJInternational Consortium of Investigative Journalists - ICIJ · Wed, 05 Aug 2026 19:30:24 GMT

Timeline

Mon, 10 Aug 2026 09:15:00 GMTSamsung Bioepis Files South Korea's First Approval for Biosimilar of Merck's $32.4 Billion Cancer Drug Keytruda - finance.biggo.com
Sun, 09 Aug 2026 11:00:17 GMTPatients in Illinois starting to receive experimental pancreatic cancer drug: ‘Game changer’ - Chicago Tribune
Fri, 07 Aug 2026 22:12:34 GMTRecovery for Replimune: Accelerated Approval for Cancer Drug Twice Spurned by FDA - MedCity News
Fri, 07 Aug 2026 19:33:00 GMTReplimune Wins FDA Skin Cancer Drug Approval on Third Try. Why the Stock Is Tumbling. - Barron's
Fri, 07 Aug 2026 13:29:00 GMT'We're excited and ready to go': Fast-growing Revolution Medicines preps potential launch of blockbuster pancreatic cancer drug - The Business Journals
Fri, 07 Aug 2026 13:27:22 GMTFDA Approves Replimune Skin Cancer Drug After Rejections - Medscape

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Cancer Drug With.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

7 distinct publisher/source names are currently connected to this entity page.